Prevalence of Thyroid Dysfunction in a Chinese Population with Different Glucose Intolerance Status: A Community-Based Cross-Sectional Study

References

• Canaris GJ, Manowitz NR, Mayor G, Ridgway EC. The Colorado thyroid disease prevalence study. Arch Intern Med. 2000;160(4):526–534. doi:10.1001/archinte.160.4.526
   PubMed Web of Science ®Google Scholar
• Kadiyala R, Peter R, Okosieme OE. Thyroid dysfunction in patients with diabetes: clinical implications and screening strategies. Int J Clin Pract. 2010;64(8):1130–1139. doi:10.1111/j.1742-1241.2010.02376.x
   PubMed Web of Science ®Google Scholar
• Duntas LH, Orgiazzi J, Brabant G. The interface between thyroid and diabetes mellitus. Clin Endocrinol (Oxf). 2011;75(1):1–9. doi:10.1111/j.1365-2265.2011.04029.x
   PubMed Web of Science ®Google Scholar
• IDF. Diabetes atlas - 9th edition; 2019. Available from: www.diabetesatlas.org. Accessed November 3, 2020.
   Google Scholar
• Xu Y, Wang L, He J, et al. Prevalence and control of diabetes in Chinese adults. JAMA. 2013;310(9):948–959. doi:10.1001/jama.2013.168118
   PubMed Web of Science ®Google Scholar
• Shan Z, Chen L, Lian X, et al. Iodine status and prevalence of thyroid disorders after introduction of mandatory universal salt iodization for 16 years in China: a cross-sectional study in 10 cities. Thyroid. 2016;26(8):1125–1130. doi:10.1089/thy.2015.0613
   PubMed Web of Science ®Google Scholar
• Hollowell JG, Staehling NW, Flanders WD, et al. Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): national health and nutrition examination survey (NHANES III). J Clin Endocrinol Metab. 2002;87(2):489–499.
   PubMed Web of Science ®Google Scholar
• Radaideh AR, Nusier MK, Amari FL, et al. Thyroid dysfunction in patients with type 2 diabetes mellitus in Jordan. Saudi Med J. 2004;25(8):1046–1050.
   PubMedGoogle Scholar
• Perros P, McCrimmon RJ, Shaw G, Frier BM. Frequency of thyroid dysfunction in diabetic patients: value of annual screening. Diabet Med. 1995;12(7):622–627. doi:10.1111/j.1464-5491.1995.tb00553.x
   PubMed Web of Science ®Google Scholar
• Han C, He X, Xia X, et al. Subclinical hypothyroidism and type 2 diabetes: a systematic review and meta-analysis. PLoS One. 2015;10(8):e0135233.
   PubMed Web of Science ®Google Scholar
• Gronich N, Deftereos SN, Lavi I, Persidis AS, Abernethy DR, Rennert G. Hypothyroidism is a risk factor for new-onset diabetes: a cohort study. Diabetes Care. 2015;38(9):1657–1664. doi:10.2337/dc14-2515
   PubMed Web of Science ®Google Scholar
• Smithson MJ. Screening for thyroid dysfunction in a community population of diabetic patients. Diabet Med. 1998;15(2):148–150. doi:10.1002/(SICI)1096-9136(199802)15:2<148::AID-DIA540>3.0.CO;2-H
   PubMed Web of Science ®Google Scholar
• Palma CC, Pavesi M, Nogueira VG, et al. Prevalence of thyroid dysfunction in patients with diabetes mellitus. Diabetol Metab Syndr. 2013;5(1):58. doi:10.1186/1758-5996-5-58
   PubMed Web of Science ®Google Scholar
• Diez JJ, Sanchez P, Iglesias P. Prevalence of thyroid dysfunction in patients with type 2 diabetes. Exp Clin Endocrinol Diabetes. 2011;119(4):201–207. doi:10.1055/s-0031-1271691
   PubMedGoogle Scholar
• Al-Geffari M, Ahmad NA, Al-Sharqawi AH, Youssef AM, Alnaqeb D, Al-Rubeaan K. Risk factors for thyroid dysfunction among type 2 diabetic patients in a highly diabetes mellitus prevalent society. Int J Endocrinol. 2013;2013:417920. doi:10.1155/2013/417920
   PubMed Web of Science ®Google Scholar
• Thvilum M, Brandt F, Almind D, Christensen K, Brix TH, Hegedus L. Type and extent of somatic morbidity before and after the diagnosis of hypothyroidism. a nationwide register study. PLoS One. 2013;8(9):e75789. doi:10.1371/journal.pone.0075789
   PubMedGoogle Scholar
• Gholampour Dehaki M, Amouzegar A, Delshad H, Mehrabi Y, Tohidi M, Azizi F. Thyroid dysfunction in patients with impaired glucose metabolism: 11 year follow up from the Tehran thyroid study. PLoS One. 2017;12(10):e0184808. doi:10.1371/journal.pone.0184808
   PubMedGoogle Scholar
• Nishi M. Diabetes mellitus and thyroid diseases. Diabetol Int. 2018;9(2):108–112.
   PubMedGoogle Scholar
• Wang C. The relationship between type 2 diabetes mellitus and related thyroid diseases. J Diabetes Res. 2013;2013:390534. doi:10.1155/2013/390534
   PubMed Web of Science ®Google Scholar
• Fukuchi M, Shimabukuro M, Shimajiri Y, et al. Evidence for a deficient pancreatic beta-cell response in a rat model of hyperthyroidism. Life Sci. 2002;71(9):1059–1070. doi:10.1016/S0024-3205(02)01791-5
   PubMed Web of Science ®Google Scholar
• Ritter MJ, Amano I, Hollenberg AN. Thyroid hormone signaling and the liver. Hepatology. 2020;72(2):742–752. doi:10.1002/hep.31296
   PubMed Web of Science ®Google Scholar
• Duntas LH. Thyroid disease and lipids. Thyroid. 2002;12(4):287–293.
   PubMed Web of Science ®Google Scholar
• Nair A, Jayakumari C, Jabbar PK, et al. Prevalence and associations of hypothyroidism in indian patients with type 2 diabetes mellitus. J Thyroid Res. 2018;2018:5386129. doi:10.1155/2018/5386129
   PubMed Web of Science ®Google Scholar
• Kalra S, Aggarwal S, Khandelwal D. Thyroid dysfunction and type 2 diabetes mellitus: screening strategies and implications for management. Diabetes Ther. 2019;10(6):2035–2044. doi:10.1007/s13300-019-00700-4
   PubMed Web of Science ®Google Scholar
• Mirza S, Hossain M, Mathews C, et al. Type 2-diabetes is associated with elevated levels of TNF-alpha, IL-6 and adiponectin and low levels of leptin in a population of Mexican Americans: a cross-sectional study. Cytokine. 2012;57(1):136–142.
   PubMed Web of Science ®Google Scholar
• Lu L, Zhang Q, Pu LJ, et al. Elevation of tumor necrosis factor-alpha, interleukin-1beta and interleukin-6 levels in aortic intima of Chinese Guizhou minipigs with streptozotocin-induced diabetes. Chin Med J. 2007;120(6):479–484. doi:10.1097/00029330-200703020-00009
   PubMedGoogle Scholar
• Zakarija M, McKenzie JM. Influence of cytokines on growth and differentiated function of FRTL5 cells. Endocrinology. 1989;125(3):1260–1265. doi:10.1210/endo-125-3-1260
   PubMedGoogle Scholar
• Molnar I, Balazs C, Szegedi G, Sipka S. Inhibition of type 2,5ʹ-deiodinase by tumor necrosis factor alpha, interleukin-6 and interferon gamma in human thyroid tissue. Immunol Lett. 2002;80(1):3–7. doi:10.1016/S0165-2478(01)00301-7
   PubMedGoogle Scholar
• Aust G, Heuer M, Laue S, et al. Expression of tumour necrosis factor-alpha (TNF-alpha) mRNA and protein in pathological thyroid tissue and carcinoma cell lines. Clin Exp Immunol. 1996;105(1):148–154. doi:10.1046/j.1365-2249.1996.d01-726.x
   PubMed Web of Science ®Google Scholar
• Diez JJ, Hernanz A, Medina S, Bayon C, Iglesias P. Serum concentrations of tumour necrosis factor-alpha (TNF-alpha) and soluble TNF-alpha receptor p55 in patients with hypothyroidism and hyperthyroidism before and after normalization of thyroid function. Clin Endocrinol (Oxf). 2002;57(4):515–521.
   PubMed Web of Science ®Google Scholar
• Nilsson J, Jovinge S, Niemann A, Reneland R, Lithell H. Relation between plasma tumor necrosis factor-alpha and insulin sensitivity in elderly men with non-insulin-dependent diabetes mellitus. Arterioscler Thromb Vasc Biol. 1998;18(8):1199–1202. doi:10.1161/01.ATV.18.8.1199
   PubMedGoogle Scholar
• Stanicka S, Vondra K, Pelikanova T, Vlcek P, Hill M, Zamrazil V. Insulin sensitivity and counter-regulatory hormones in hypothyroidism and during thyroid hormone replacement therapy. Clin Chem Lab Med. 2005;43(7):715–720. doi:10.1515/CCLM.2005.121
   PubMedGoogle Scholar
• Volzke H, Ludemann J, Robinson DM, et al. The prevalence of undiagnosed thyroid disorders in a previously iodine-deficient area. Thyroid. 2003;13(8):803–810. doi:10.1089/105072503768499680
   PubMedGoogle Scholar